Publications by authors named "Jane Bryce"

Claim this Profile
H
Hidden in plain sight - Survival consequences of baseline symptom burden in women with recurrent ovarian cancer.
Felicia Roncolato, Madeleine T King, Rachel L O'Connell, Yeh Chen Lee, Florence Joly, Jane Bryce

Gynecol Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cultural adaptation of the Italian version of the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE®).
Caterina Caminiti, Jane Bryce, Silvia Riva, Diane Ng, Francesca Diodati

Tumori· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measure of Ovarian Symptoms and Treatment concerns (MOST) indexes and their associations with health-related quality of life in recurrent ovarian cancer.
Rachel Campbell, Daniel S J Costa, Martin R Stockler, Yeh Chen Lee, Jonathan A Ledermann, Jane Bryce

Gynecol Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study.
Yeh Chen Lee, Madeleine T King, Rachel L O'Connell, Anne Lanceley, Florence Joly, Jane Bryce

Int J Gynecol Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system.
Silvia Riva, Laura Arenare, Massimo Di Maio, Fabio Efficace, Vincenzo Montesarchio, Jane Bryce

BMJ Open· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A qualitative analysis and development of a conceptual model assessing financial toxicity in cancer patients accessing the universal healthcare system.
Silvia Riva, Fabio Efficace, Massimo Di Maio, Jane Bryce, Laura Del Campo

Support Care Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocol.
Silvia Riva, Jane Bryce, Francesco De Lorenzo, Laura Del Campo, Massimo Di Maio

BMJ Open· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer.
Madeleine T King, Martin R Stockler, Rachel L O'Connell, Luke Buizen, Florence Joly, Jane Bryce

Qual Life Res· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study.
Sandro Pignata, Giovanni Scambia, Alessandra Bologna, Simona Signoriello, Ignace B Vergote, Jane Bryce

J Clin Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients.
Ettore Capoluongo, Gillian Ellison, José Antonio López-Guerrero, Frederique Penault-Llorca, Marjolijn J L Ligtenberg, Jane Bryce

Semin Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes in the evaluation of toxicity of anticancer treatments.
Massimo Di Maio, Ethan Basch, Jane Bryce, Francesco Perrone

Nat Rev Clin Oncol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapies.
Alexandre Chan, Michael C Cameron, Benjamin Garden, Christine B Boers-Doets, Katja Schindler, Jane Bryce

Support Care Cancer· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials.
Massimo Di Maio, Ciro Gallo, Natasha B Leighl, Maria Carmela Piccirillo, Gennaro Daniele, Jane Bryce

J Clin Oncol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary.
Aikou Okamoto, Rosalind M Glasspool, Seiji Mabuchi, Noriomi Matsumura, Hiroyuki Nomura, Jane Bryce

Int J Gynecol Cancer· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the uterine corpus and cervix.
Kosei Hasegawa, Shoji Nagao, Masanori Yasuda, David Millan, Akila N Viswanathan, Jane Bryce

Int J Gynecol Cancer· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-rash dermatologic adverse events related to targeted therapies.
Jane Bryce, Christine B Boers-Doets

Semin Oncol Nurs· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New biological treatments for gynecological tumors: focus on angiogenesis.
Gennaro Daniele, Massimo Di Maio, Maria Carmela Piccirillo, Pasqualina Giordano, Ida Capuano, Jane Claire Bryce

Expert Opin Biol Ther· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group.
Rebecca K S Wong, René-Jean Bensadoun, Christine B Boers-Doets, Jane Bryce, Alexandre Chan

Support Care Cancer· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Roadmap for the European Network of Gynaecological Trial groups (ENGOT) Trials.
Ignace Vergote, Gabriele Elser, Benedicte Votan, Laura Farrelly, Joke De Roover, Jane Bryce

Int J Gynecol Cancer· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nursing management of patients with metastatic melanoma receiving ipilimumab.
Jane Bryce, Claudia Passoni

Oncol Nurs Forum· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-related fatigue in Italian cancer patients: validation of the Italian version of the Brief Fatigue Inventory (BFI).
Gianluca Catania, Carol Bell, Simona Ottonelli, Monia Marchetti, Jane Bryce

Support Care Cancer· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of stromal CXCR4 impairs development of lung metastases.
Crescenzo D'Alterio, Antonio Barbieri, Luigi Portella, Giuseppe Palma, Marianeve Polimeno, Jane Bryce

Cancer Immunol Immunother· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing arthralgia in a postmenopausal woman taking an aromatase inhibitor for hormonesensitive early breast cancer: a case study.
Jane Bryce, Martina Bauer, Peyman Hadji

Cancer Manag Res· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab in non-small-cell lung cancer.
Guido Carillio, Agnese Montanino, Raffaele Costanzo, Claudia Sandomenico, Maria Carmela Piccirillo, Jane Bryce

Expert Rev Anticancer Ther· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Italian ethical committee intervention in a case of embryo-fetal medicine.
Nunzia Cannovo, Paola Buccelli, Jane Bryce

Med Law· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis